Tumor Heterogeneity Underlies Differential Cisplatin Sensitivity in Mouse Models of Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Tumor Heterogeneity Underlies Differential Cisplatin Sensitivity in Mouse Models of Small-Cell Lung Cancer

Published:2019-06 Issue:11 Volume:27 Page:3345-3358.e4
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Böttger Franziska,Semenova Ekaterina A.,Song Ji-Ying,Ferone Giustina,van der Vliet Jan,Cozijnsen Miranda,Bhaskaran Rajith,Bombardelli Lorenzo,Piersma Sander R.,Pham Thang V.,Jimenez Connie R.,Berns Anton

Funder

European Research Council

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference58 articles.

1. Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer;Allison Stewart;Oncotarget,2017

2. HTSeq—a Python framework to work with high-throughput sequencing data;Anders;Bioinformatics,2015

3. ASCL1 and NEUROD1 reveal heterogeneity in pulmonary neuroendocrine tumors and regulate distinct genetic programs;Borromeo;Cell Rep.,2016

4. A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer;Calbo;Cancer Cell,2011

5. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification;Cox;Nat. Biotechnol.,2008

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AKR1C3 promotes progression and mediates therapeutic resistance by inducing epithelial-mesenchymal transition and angiogenesis in small cell lung cancer;Translational Oncology;2024-09

2. Characteristics of molecular subtypes and cinical outcomes in the immunotherapy Queue of extensive-stage small cell lung cancer patients;BMC Pulmonary Medicine;2024-08-29

3. GCN2 is a determinant of the response to WEE1 kinase inhibition in small-cell lung cancer;Cell Reports;2024-08

4. Small Cell Lung Cancer Neuronal Features and Their Implications for Tumor Progression, Metastasis, and Therapy;Molecular Cancer Research;2024-06-24

5. The Evolving Scenario of ES-SCLC Management: From Biology to New Cancer Therapeutics;Genes;2024-05-27